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The Constitutive Capacity of Human Keratinocytes
to Kill Staphylococcus aureus Is Dependent
on b-Defensin 3
Kevin O. Kisich1,2, Michael D. Howell1, Mark Boguniewicz1,2, Heather R. Heizer1, Nori U. Watson1
and Donald Y.M. Leung1,2
Normal skin is often exposed to bacteria, including potent pathogens such as E. coli, Staphylococcus aureus,
and Streptococcus sp., but these microbes usually do not cause skin inflammation or infection in healthy
individuals. Therefore, we hypothesized that there must be a constitutive mechanism for rapid destruction and
elimination of small numbers of bacteria which penetrate the stratum corneum from everyday activities. This
study found that exposure of keratinocytes cultured from a number of individuals to S. aureus resulted in
approximately 2–3 log better killing than by HaCaT cells within 1 hour. Killing required contact between the
keratinocytes and the bacteria, but was not dependent on internalization. Contact between the bacteria and the
keratinocytes resulted in rapid deposition of several antimicrobial peptides onto the bacteria, but only human
b-defensin (HBD) 3 accumulated at levels sufficient to account for killing when S. aureus were exposed to
human skin explants. Blocking peptide binding of HBD3 inhibited killing of the bacteria, indicating an essential
role for b-defensin 3 in the constitutive killing of bacteria by normal keratinocytes.
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INTRODUCTION
The skin is exposed to bacteria, including potent pathogens
almost continually. However, infection of normal healthy
skin rarely occurs. Staphylococcus aureus is an important
human pathogen, which can be isolated from the skin or
nares of approximately 30% of the population (Kluytmans
et al., 1997; Fridkin et al., 2005). S. aureus is a primary
cause of skin and soft tissue infections (Rennie et al.,
2003), necrotizing fasciitis (Miller et al., 2005), and sepsis
(Biedenbach et al., 2004). Therefore, it is important to
understand the innate mechanisms employed by the normal
epidermis to prevent invasion and infection by bacteria in
general, and S. aureus in particular.
The superficial cornified layer of the epidermis is an
important aspect of the defensive barrier presented by the
skin. However, this layer is frequently breached by small
abrasions from everyday activities. This process undoubtedly
introduces bacteria directly into the layers of viable
keratinocytes, which make up the epidermis. It is well known
that keratinocytes can sense the presence of bacteria via Toll-
like receptors (Esche et al., 2004), which results in synthesis
and secretion of inflammatory mediators, and the recruitment
of antimicrobial effector cells such as macrophages and
neutrophils (Mempel et al., 2003). These phagocytes are
usually credited as the first line of defense against microbial
invasion via the skin (Janeway et al., 2005).
However, in addition to Toll-like receptors, keratinocytes
themselves bear some surface receptors in common with
professional phagocytes, including Fc receptors (Tigalonowa
et al., 1990; Bjerke et al., 1994), and complement receptors
(Hunyadi et al., 1991; Dovezenski et al., 1992). In addition,
keratinocytes can be induced to synthesize reactive nitrogen
intermediates (RNIs), defensins, and cathelicidin (Kroll et al.,
1999; Ali et al., 2001; Dorschner et al., 2001), which are
potent microbicides. We have previously shown that
keratinocytes in the epidermis contain sufficient inducible
antimicrobial peptides (AMPs) to contribute to microbial
killing (Ali et al., 2001). In addition, Braff et al. (2005) have
shown that cathelicidin contributes partially to direct activity
against cathelicidin-sensitive S. aureus mutants. Despite
these observations, the biological significance of keratinocyte
expression of AMPs in human skin is not completely worked
out. We have developed an ex vivo model to examine the
interaction and elimination of S. aureus by keratinocytes in
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human skin explants, and shown that these cells possess a
novel constitutive mechanism to kill S. aureus within minutes
of contact between the bacteria and the cell surface. The
mechanism of this killing depends on deposition of human
b-defensin (HBD)-2 and -3 onto the surface-bound bacteria.
These studies highlight the essential role that keratinocytes
play in deployment of AMPs to rapidly kill S. aureus, which
penetrate the stratum corneum.
RESULTS
During the course of examining biopsies of human skin
exposed to Texas Red-labeled S. aureus, we observed that the
keratinocytes in the viable epidermal layers which were
exposed to the bacteria rapidly bound the bacteria, and
accumulated Texas Red-labeled debris derived from the
bacteria. Figure 1 represents the pattern of binding and
accumulation observed from 12 donors. Some of the cells in
the keratinocyte layers contained what appeared to be
accumulations of cell envelope material in the cytoplasm.
We hypothesized that the label initially became associated
with the cells as intact bacteria, and was then rapidly digested
and internalized by keratinocytes. As internalization was
mainly observed near the edges of the biopsy, and toward the
middle of the epidermal layer, we hypothesized that viable
keratinocytes, rather than non-viable cell remnants of the
cornified layers are most active in this regard. In order to test
this hypothesis, we placed primary human keratinocytes into
culture, and allowed them to differentiate in the presence of
Ca2þ for 5 days. When S. aureus were labeled with Texas
Red and added to the cultured human keratinocytes, they
became associated with the cells within 5 minutes (Figure 2a).
After 15 minutes, the keratinocytes had internalized several
bacteria per cell, and most of the red fluorescence was
associated with recognizable bacteria within the cytoplasm
(Figure 2b). Internalization rather than simple surface
association is supported by three-dimensional microscopy,
clearly showing the plasma membrane surrounding the
bacteria in all three view axes (Figure S1). Examination of
the cultures after 1 hour, however, revealed that the majority
of the red fluorescence was no longer associated with
recognizable bacteria, suggesting that the Texas Red label
and the cellular macromolecules to which they were
covalently attached had been removed from the bacteria
(Figure 2c). Therefore, we hypothesized that the bacteria
were destroyed by the cells. Although the cells shown in
Figure 2a–c were quite active in accumulation of S. aureus,
an overview of the cultures at 1 hour revealed that only
certain groups of cells in the culture actively internalized
S. aureus, whereas other cells were completely inactive in this
regard (Figure 2d). This apparent destruction of S. aureus by
human keratinocytes has not been previously reported, so we
sought to test directly whether contact between the keratino-
cytes and the bacteria resulted in loss of bacteria viability.
In order to determine the capacity of keratinocytes to kill
S. aureus, it was necessary to use a technique which could
quantitate the total number of organisms which came into
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Figure 1. Accumulation of S. aureus debris by keratinocytes in human skin.
Four representative biopsies (n¼ 12) of human skin exposed to Texas Red-
labeled S. aureus (Wood 46) (red, arrow) for 30 minutes. After fixation
and mounting, the tissues were counterstained with FITC wheat germ
agglutinin (green) and DAPI (Blue). The images are single confocal planes
through the samples. Arrows highlight S. aureus particles, which appear
to still contain DNA. Bar¼ 20 mm.
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Figure 2. Accumulation of S. aureus (Wood 46) and destruction by cultured
human keratinocytes. (a) A single confocal plane through a representative
(three experiments) keratinocyte (wheat germ agglutinin – Oregon Green,
green) exposed to 1 106 serum opsonized S. aureus (Wood 46)/ml for
5 minutes has bound bacteria (arrows) (Texas Red, red). (b) After 15 minutes,
keratinocytes have internalized multiple bacteria (arrows). (c) After 1 hour,
keratinocytes have accumulated substantial amounts of Texas Red-labeled
material derived from S. aureus. (d) Low magnification view of the culture,
showing clusters of cells, which accumulate S. aureus. Cell nuclei (N) and
bacterial DNA are presented in blue (DAPI). Bar¼ 10 mm.
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contact with the keratinocytes, and those which remained
viable over time. This was accomplished by labeling the
bacteria with 3H uracil, and determining the amount of
radioactivity associated with a single colony-forming unit at
the beginning of the experiment. Table 1 shows that the
bacteria grew very little in keratinocyte growth medium
(KGM), yet retained the 3H uracil label. Figure 3a is
representative of three experiments, and shows the results
of exposing 3H-labeled S. aureus to either a keratinocyte-like
cell line, HaCaT (Scalettar et al., 1996), or to primary human
keratinocytes over 5 hours. After only 1 hour of exposure to
primary keratinocytes, they killed 2–3 log more bacteria than
HaCaT cells. This suggested that normal human keratinocytes
express a mechanism for rapidly killing S. aureus, which
come into contact with them. This was not an artifact of
lysing the cells to recover the bacteria, because bacteria
exposed to HaCaT cells were processed in the same manner,
yet remained viable. It was also not due to residual antibiotics
in the medium, as washing out the antibiotics 48 hours before
the experiment yielded the same results as washing them out
24 hours before the experiment (Figure S2). Contact between
the keratinocytes and the bacteria was required for killing, as
conditioned medium from S. aureus-stimulated cultures had
no effect on the viability of S. aureus when exposed for the
same duration (data not shown). In a similar experiment,
labeled S. aureus were exposed to human peripheral blood
neutrophils. The neutrophils were able to accumulate, and
kill S. aureus to a greater degree, than the keratinocytes or the
HaCaT cells, consistent with their role as professional
microbicidal phagocytes (Janeway et al., 2005).
As keratinocytes express Fc and complement receptors
commonly associated with phagocytes (Tigalonowa et al.,
1990), and have been shown to endocytose different types of
particles, we hypothesized that primary human keratinocytes
might utilize internalization as part of the killing mechanism,
similar or identical to the killing mechanism of neutrophils
and macrophages.
There are two processes by which particles as large as S.
aureus might be internalized by keratinocytes: macropinocy-
tosis and phagocytosis. We next sought to determine the role
of each process during killing and internalization of S. aureus.
Macropinocytosis and phagocytosis can be specifically
inhibited by amiloride and colchicine, respectively (Bou-
kamp et al., 1988; West et al., 1989). Therefore, these
pharmacologic agents provide tools to determine the
contribution of each of these internalization pathways to
uptake of S. aureus by keratinocytes. Figure 4 is representa-
tive of three experiments, and shows that both colchicine
(Figure 4a) and amiloride (Figure 4b) inhibit internalization of
S. aureus by keratinocytes in a dose-dependent manner. This
confirms the above results obtained by three-dimensional
microscopy (Figure S1). These results also indicate that the
internalization of the bacteria is an active cellular process,
rather than invasion of the cells by the bacteria. A maximum
of approximately 17% of serum-opsonized S. aureus, and
10% of non-opsonized, cell-associated bacteria were inter-
nalized (i.e., resistant to gentamicin) in the absence of any
inhibitor. Colchicine inhibited internalization of serum
opsonized viable S. aureus, as determined by lysis of the
cultures and plating, by approximately 66% when 33 mM was
added to the medium before addition of the opsonized
Table 1. Growth of S. aureus and retention of 3H uracil in KGM
Time after inoculation 0 1 2 3 5
CPM 6.3106 6.2106 6.0106 6.3106 6.2 106
CFU 2.24105 2.38105 2.17105 2.52105 2.88 105
CPM/CFU 28.1 26.1 27.6 25.0 21.5
CFU, colony-forming unit; CPM, counts per minute; KGM, keratinocyte growth medium; S. aureus, Staphylococcus aureus.
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Figure 3. Comparison of microbicidal activity of HaCaT versus normal
human keratinocytes. HaCaT and normal human keratinocytes were
incubated with S. aureus (ATCC29213) for 1 hour. After washing, the
monolayers were lysed and total bacteria determined radiometrically,
whereas viable bacteria were determined by colony-forming unit. The
number of total and viable bacteria is shown on the y axis as a function of
time co-culture. (a) Primary human keratinocytes compared with HaCaT cells.
(b) Primary human keratinocytes compared with primary human neutrophils.
*Po0.01 relative to HaCaT at the same time point. zPo0.01 relative to
neutrophils at the same time point. Results are representative of three
experiments. Error bars represent standard deviation of triplicate samples.
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bacteria (Figure 4a). This concentration was sufficient to
blocko95% of horseradish peroxidase uptake in preliminary
experiments (data not shown). Increasing concentrations of
amiloride were able to inhibit internalization of cell-
associated, viable S. aureus, which had not been opsonized,
with maximum inhibition occurring at the highest concentra-
tion of 10 mM. This indicates that in the absence of
opsonization, the internalization pathway responsible for
most of the internalization is amiloride sensitive, and in that
respect similar to macropinocytosis. Therefore, internaliza-
tion of S. aureus by keratinocytes can occur via pathways
dependent on both phagocytosis and macropinocytosis.
However, although inhibition of macropinocytosis and
phagocytosis, inhibited internalization, neither inhibitor
blocked killing of the bacteria by the cells as shown in
Figure 4c and d. Furthermore, neither chemical had any
effect on the growth rate of the bacteria (data not shown).
Therefore, killing of S. aureus appears to be independent
of internalization, suggesting that it may occur soon after
contact between the bacteria and the cell surface. Indeed,
Figure 4c and d suggested that keeping the bacteria at the
surface of the cells by inhibiting internalization actually
enhances killing. Understanding the microbicidal mechan-
ism, which occurs after binding or during internalization,
resulting in loss of bacterial viability is important. In order to
accomplish this, we examined S. aureus in association with
keratinocytes for evidence of exposure to the most likely
antimicrobial mechanisms: reactive nitrogen production and
release of AMP.
Assessment of keratinocyte cultures for production of RNIs
showed that RNIs were indeed generated in response to S.
aureus, but only became detectable after 24 hours of
exposure (data not shown). Inclusion of increasing amounts
of N-nitro-L-arginine methyl ester (l-NAME) in the killing
assay to inhibit any production of RNI did not inhibit the
ability of keratinocytes to kill S. aureus (Figure 5). Therefore,
we concluded that the rapid bactericidal activity of kerati-
nocytes was not dependent on production of RNI.
Additional keratinocyte products, which may be important
for the microbicidal activity are AMP, including LL37, HBD1,
HBD2, and HBD3. We have measured the sensitivity of S.
aureus to these AMP both in low salt medium (0.01 tryptic
soy broth, 10 mM NaPOh, pH 7.2), and the KGM, which
contains physiological levels of salt. Table 2 illustrates the
concentrations of each AMP, which killed 99.9% of S. aureus
in 2 hours, and standard deviation of at least three indepen-
dent experiments for each peptide (defined as the bactericidal
concentration, BC99.9). In KGM, HBD3 was the most potent
of the four AMP tested (BC99.9¼ 10.7075.75 mM), followed
by LL37 (43.68718.39mM) and HBD2 (483.03743.22mM).
We were unable to detect any microbicidal activity of HBD1
for S. aureus.
Next, we sought to determine how much of each AMP the
S. aureus were exposed to when in contact with the
keratinocytes. In order to accomplish this, we exposed S.
aureus in KGM to increasing concentrations of each peptide,
rapidly rinsed them by centrifugation, and then fixed the
bacteria with paraformaldehyde. Simultaneously, S. aureus
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Figure 4. Pharmacologic inhibition of internalization. (a) Percentage of viable, serum opsonized S. aureus (ATCC29213) recovered from lysates of normal
human keratinocytes (NHK) cells after 30 minutes pretreatment with colchicines, and killing of extracellular S. aureus with gentamicin. (b) Recovery of viable
non-opsonized S. aureus from NHK after 30 minutes preincubation with amiloride at the concentrations shown on the x axis, and killing of extracellular S.
aureus with gentamicin. (c) Ability of keratinocytes to kill S. aureus with increasing concentrations of colchicine, presented as total versus viable bacteria.
(d) Ability of keratinocytes to kill S. aureus in the presence of amiloride, presented as total versus viable bacteria. Error bars represent standard deviation of
triplicate samples. Results are representative of three experiments. *Po0.05 relative to no inhibitor.
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were exposed to cultures of differentiated keratinocytes for
1 hour, rinsed, and fixed with paraformaldehyde. Both the
bacteria and the cell cultures were then stained using
immunofluorescent reagents specific for the AMP in question
as shown in Figure 6. The AMP fluorescence intensity of the
bacteria exposed to the pure peptides was then compared
with the intensity of the bacteria in contact with the
keratinocytes. AMP exposure of the S. aureus in contact with
keratinocytes was then estimated based on the curve of
fluorescence intensity versus concentration of AMP. The
results, which are representative of three experiments, shown
in Figure 6c and d reveal how the fluorescence intensity of
antibody staining of the AMP increased with increasing
exposure of the bacteria to purified AMP. Images of S. aureus
in contact with keratinocytes (Figure 6a and b) are placed
near the standard image with most similar intensity. Regres-
sion analysis of intensities derived from at least 20 bacteria
from each of triplicate samples (N¼ 60) revealed that the
bacteria were exposed to 34.2 mM HBD1, 120.9mM HBD2,
34 mM HBD3, and 13.8 mM LL37 when in contact with the
keratinocytes. The amount of HBD3 deposited on the
S. aureus in contact with the cells was well above the
BC99.9. In contrast, HBD2 and LL37 were only 25 and 32% of
their respective BC99.9. The level of HBD1 deposited on the
bacteria would not be expected to affect viability under the
conditions tested. Therefore, we concluded that HBD3 levels
were sufficient to account for most of the killing by cultured
keratinocytes, consistent with the observation of destruction
and loss of viability in Figures 2 and 3. The values of
equivalent in vitro exposure of the AMP are summarized in
Table 3.
Exposure of S. aureus to human skin explants in a very
similar assay was then performed to determine if the same
AMPs were deposited on bacteria coming in contact with
keratinocytes in situ. Four biopsies were collected from each
of four normal donors and placed into KGM overnight at
371C to allow for involution of damaged cells at the cut
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Figure 5. Effect of inhibitors of reactive nitrogen generation. Keratinocytes
treated with increasing concentrations of l-NAME to inhibit generation of RNI
were exposed to S. aureus (ATCC 29213). The number of total (squares) and
viable cell-associated bacteria (diamonds). Bacteria exposed to l-NAME in
KGM in the absence of cells are shown by triangles. Error bars (in some cases
smaller than the plot symbols) represent standard deviation of triplicate
samples. Results are representative of three experiments.
Table 2. BC99.9 values of AMP in 0.01 TSB and
KGM for S. aureus1
Peptide 0.01 TSB, 10 lM NaPOH KGM
LL37 2.370.54mM 43.68718.39 mM1
HBD1 41,000 mM 41,000 mM
HBD2 432.99730.75 mM 483.03743.22 mM
HBD3 4.6474.08 mM 10.7075.75 mM1
AMP, antimicrobial peptide; BC99.9, bactericidal concentration 99.9;
KGM, keratinocyte growth medium; TSB, tryptic soy broth; S. aureus,
Staphylococcus aureus.
1Po0.05 by t-test, relative to the BC99.9 of the same peptide in 0.01
TSB, 10 mM NaPOH.
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Figure 6. Intensity of AMP staining on S. aureus (Wood 46) after exposure to
pure peptide or keratinocytes. Single confocal images of S. aureus (Wood 46)
labeled with Texas Red (red) were exposed to increasing concentrations of
LL37 (left column), or HBD3 (right column), and stained with antibodies
specific for those peptides. The rabbit isotype control is shown to the right. In
parallel, bacteria were exposed to keratinocyte cultures for 1 hour, fixed, and
stained with the same antibodies. Representative bacteria in association with
keratinocytes stained for (a) LL37 or (b) HBD3 are placed near the standard
image of similar intensity. Bar¼ 5mm. The intensity of each exposure series is
plotted against the concentration of (c) LL37 or (d) HBD3. Regression analysis,
line equations, and correlation coefficients are shown on each graph.
2372 Journal of Investigative Dermatology (2007), Volume 127
KO Kisich et al.
HBD3 in Microbicidal Activity of Keratinocytes
margins. S. aureus was then added to the tissues for 1 hour,
after which the tissues were rinsed vigorously and prepared
for imaging. Four biopsies were examined from each donor,
with serial sections stained with control antibody, or antibody
to each AMP of interest so that at least 10 bacteria in contact
with the keratinocyte layers were quantitated for each
sample/stain combination. In addition, specificity of the
anti-HBD3 antibody was demonstrated by preabsorbing the
antibody with synthetic HBD3 (Figure S3). Figure 7 shows
that S. aureus were bound by keratinocytes in human skin in
a manner similar to that of cultured keratinocytes, and that
they expressed LL37, HBD1, and HBD3. HBD2 was only
detected in rare cells. LL37, HBD1, and HBD3 rapidly
became associated with S. aureus in contact with the
keratinocytes, as shown in Figure 8. HBD1 was deposited
on the bacteria equivalent to exposure in vitro at
37.278.34 mM, which was far below its BC99.9 in vitro.
HBD3 was deposited equivalent to in vitro exposure at
86.9479.38 mM, which was approximately 8-fold higher than
the amount required for efficient killing. LL37 was deposited
poorly on the surface-bound bacteria, equivalent to less than
5 mM of in vitro exposure, which was the lower limit of
quantitation. The kinetics and degree of HBD1 deposition
were generally similar to that observed for the cultured
keratinocytes, whereas HBD3 deposition was greater, and
LL37 and HBD2 deposition were reduced. Therefore, only
HBD3 was deposited in sufficient quantity for S. aureus
killing by keratinocytes in skin. Exposure levels of S. aureus in
contact with cultured keratinocytes, and keratinocytes in
human skin are summarized in Table 3. However, in order to
demonstrate that these AMPs were involved in the micro-
bicidal mechanism, it was important to study the effect of
their inhibition on the ability of keratinocytes to kill microbes.
To provide further data supporting constitutive expression
of HBD3 in unstimulated human skin, we preformed
quantitative real-time PCR to determine the number of copies
of HBD3 mRNA per mg of human skin (punch biopsies). RNA
extracted from skin biopsies of 12 individuals represented
approximately 100,382731,631 (SEM) copies of HBD3 RNA
per mg of tissue. When compared to levels of glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), there were an
average of 41,831 copies of GAPDH mRNA for each copy of
HBD3 mRNA in unstimulated skin. However, in some
samples there were as many as one copy of HBD3 mRNA
for 246 copies of GAPDH mRNA, and in others there were as
few as one per 320,000. The median value was one copy of
HBD3 mRNA per 2,080 copies of GAPDH, indicating
significant expression of the HBD3 gene in the absence of
induction. These data are summarized in Table 4.
In order to determine which peptides were necessary for
killing of S. aureus, we conducted the killing experiments in
the presence of antibodies to each of the AMP of interest, to
determine the effect of preventing them from binding to the
bacteria in contact with the cells. Specificity of each antibody
for the target AMP was determined in preliminary experi-
ments by using the antibodies to block killing of S. aureus
exposed to the various purified AMP in KGM in vitro. The
antibodies each blocked killing by their cognate peptide, but
not to any of the other peptides. The effects of the antibodies
on the ability of keratinocytes to kill S. aureus are shown in
Figure 9. These results show that antibodies to human
neutrophil peptide 1, which is not present in keratinocytes
and serves as a control, did not significantly inhibit killing of
the bacteria. Similarly, antagonism of LL37 and HBD1 had no
significant effect on the killing ability of the keratinocytes.
However, when antibodies to HBD2 or HBD3 were added to
the cultures, concentration-dependent inhibition was ob-
served (Figure 9). The highest concentration of antibodies to
HBD2 and HBD3 reduced Staphylococcus killing by 25 and
75%, respectively, confirming that these two peptides are not
only deposited at sufficient concentration on cell-associated
bacteria to account for killing, but they are also necessary for
Table 3. Exposure of S. aureus to AMP when in
contact with keratinocytes in culture, and in human
skin
Peptide
Exposed to cultured
keratinocytes (7SEM,
n=50 bacteria)
Exposed to human skin
(7SEM, n=4
individuals)
LL37 13.873.0mM o5 mM1
HBD1 34.273.8mM 37.278.3 mMNS
HBD2 120.9730.1mM o5 mM1
HBD3 34711.2 mM 86.979.3mM1
AMP, antimicrobial peptide; NS, nonsignificant; S. aureus, Staphylococ-
cus aureus.
1Po0.05 relative to keratinocytes in culture (Student’s t-test).
(Rabbit IgG, 10 gml)
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ed
Figure 7. Expression of AMP and association of S. aureus (Wood 46) in
human skin. (a) Skin from a representative donor out of four examined has
been exposed to Texas Red-labeled S. aureus (Wood 46) (red, arrows), and
immunostained with control antibody, or (b) antibodies specific for HBD1,
(c) HBD2, (d) HBD3, or (e) LL37 (Green). Single confocal images show
nuclei were counterstained with DAPI (blue). Bar¼ 20mm.
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most of the killing of cell-associated S. aureus. In addition, as
killing could be inhibited by extracellular antibody, killing
likely takes place at the cell surface, confirming that
internalization of the bacteria is not required for killing to
occur (Figure 4).
DISCUSSION
Although it is known that induced (time course of 424 hours)
AMPs play an important role in innate immune response to
microbes, the immediate response of skin keratinocytes
during initial invasion of microbes has not been well studied.
In these studies, we have shown that human keratinocytes
possess potent constitutive antimicrobial activity, which kills
and eliminates S. aureus from the skin within 1 hour of
contact. The speed and potency with which cultured
keratinocytes were able to kill bacteria suggest that these
cells possess a previously unrecognized microbicidal capa-
city, which may contribute substantially to protection of the
epidermis, and hence the entire organism, from invasion by
microbes.
Previous studies have not considered this constitutive
activity, focusing instead on gene expression induced by
contact with microbes or microbial products (Braff et al.,
2005; Menzies and Kenoyer, 2005, 2006; Wehkamp et al.,
Green channel
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Figure 8. Accumulation of AMP on S. aureus in association with keratinocytes in situ. Skin from a representative donor, out of four examined has been exposed
to Texas Red-labeled S. aureus (red, arrows), and immunostained with (a–c) isotype control antibody, or antibodies specific for (d–f) LL37, (g–i) HBD1,
(j–l) HBD2, or (m–o) HBD3 (Green). In the single confocal planes, green fluorescence overlapping the red bacteria indicates deposition of the AMP on the
bacteria. Constrained iterative deconvolution was used for these images in order to highlight position of the fluorescence. Therefore, intensities are not to scale.
Nuclei were counterstained with DAPI (blue).
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2006). However, the constitutive activity reported herein
could make important contributions to limiting bacterial
growth following initial penetration of the stratum corneum,
such as after scratching or abrasions that would expose the
middle of the epidermis to the outside world, thereby limiting
inflammation and infection. Keratinocytes are known to
produce potently microbicidal molecules, including three
b-defensins (Ali et al., 2001), cathelicidin fragments (Sharlow
et al., 2000), and RNIs. However, no mechanism has
previously been shown for how these AMPs were utilized
by the cells to kill microbes (Kroll et al., 1999) such as
S. aureus. Our current experiments illustrate how these
defensins contribute to a previously unappreciated active
host defense role for keratinocytes.
As factors secreted into the medium had no effect on the
viability of microbes, binding of the microbes to the cells
played an important role in the killing mechanism. S. aureus
is known to bind keratinocytes efficiently in the absence of
opsonization, via fibronectin binding proteins interacting
with integrin a5b1 on the keratinocytes (Murakami et al.,
2004). We noted that exposure of cultured keratinocytes to
S. aureus resulted in rapid binding of bacteria to the cells,
followed by internalization by keratinocytes, which has been
previously noted as a virulence mechanism for S. aureus, as
the bacteria escape from the endosomes and cause apoptosis
of the keratinocytes (Bayles et al., 1998; Kintarak et al.,
2004). The kinetics of internalization also showed apparent
disappearance of the covalently attached Texas Red fluor-
ophore from viable bacteria. This could have been due to
destruction of the bacteria, and subsequent release of the
labeled macromolecules from the cells. An alternative
interpretation would be that the bacteria remained intact,
but that the label became non-uniformly distributed on the
bacteria because of cell division, or that the label and the
associated macromolecules were shed from the bacteria.
However, as our results indicate that S. aureus has a high
level of spontaneous binding to keratinocytes, and that this
contact results in loss of the majority of bacterial viability
(Figure 3), we believe that the diffuse fluorescence in the cells
after 1 hour represents bacteria which have been destroyed.
In addition to binding via the a5b1 receptor (West et al.,
1989), keratinocytes have receptors normally associated with
professional phagocytes, FcgRI, FcgRII, and FcgRIII (Tigalo-
nowa et al., 1990; Bjerke et al., 1994), which can be
upregulated by cytokine stimulation (Mempel et al., 2002).
This suggests that binding and killing of microbes by
keratinocytes shares important similarities with professional
phagocytes. Inhibition of S. aureus internalization by
keratinocytes by both amiloride and colchicine indicates
that both macropinocytosis and phagocytosis are important
internalization pathways for keratinocytes, and is not simply
a passive invasion process as previously suggested (Aufiero
et al., 2004). The conclusions we draw from these studies
differ from the conclusions of others for two reasons: first, we
have cultured the keratinocytes in higher levels of Ca2þ ,
which results in differentiation of the cells to a more mature
phenotype (Stanley and Yuspa, 1983). Second, we are
calculating the loss of bacterial viability from the initial point
of inoculation, rather than from the point of internalization by
the cells. It is clear from our results that the majority of
bacterial killing occurs before internalization when the
keratinocytes are encouraged to differentiate. Therefore, we
conclude that like macrophages and neutrophils, human
keratinocytes are microbicidal phagocytes. However, even
though killing and internalization both occurred, the experi-
ments shown in Figure 4 clearly demonstrate that internaliza-
tion is not required for the microbicidal mechanism. In
addition, the killing mechanism could be inhibited via
extracellular antibodies to HBD2 and HBD3 (Figure 9).
Despite this, internalization may still be important in limiting
Table 4. Expression of mRNA encoding GAPDH and
HBD3 mRNA in skin
mRNA encoding
Average copies
per mg (7SEM, n=9) Range
GAPDH 4.6 10973.5108/mg 1.5 106–3.9 1010
HBD3 1 10573.2104/mg 2.4103–3.4 105
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HBD, human
beta-defensin.
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Figure 9. Inhibition of keratinocyte killing of S. aureus by antibodies to
AMP. S. aureus were exposed to keratinocytes for 1 hour in the presence of
increasing concentrations of control antibody, or antibodies to LL37, HBD1,
HBD2, or HBD3. After washing, the monolayers were lysed and total bacteria
determined radiometrically, whereas viable bacteria were determined by
colony-forming unit. The number of total cell-associated and viable cell-
associated bacteria (y axis) was plotted against the dilution of each antibody
(x axis). The percentage of each bacteria culture killed was calculated from
the total versus total viable data, and is presented below the x axis. *Po0.01
relative to control antibody. Data are representative of three experiments.
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inflammation, as S. aureus contains several molecules known
to be potently inflammatory (Tokura et al., 1994; Ezepchuk
et al., 1996; Mempel et al., 2003; Matsubara et al., 2004).
Therefore, internalization of S. aureus by keratinocytes may
limit inflammation by sequestration of inflammatory sub-
stances. In addition, the constitutive microbicidal capacity of
keratinocytes is not likely to be limited to S. aureus. Glaser
et al. (2005) demonstrated that psoriasin is mainly respon-
sible for preventing E. coli from colonizing the skin. It is
possible that internalization is important for killing S. aureus
that survive the initial encounter with the cell surface, or for
killing other microbes. Indeed, Braff et al. (2005) demon-
strated that the viability of S. aureus declined for several
hours after internalization.
HBD2 and HBD3 expression has not been widely reported
in healthy skin (Nomura et al., 2003; Sorensen et al., 2006).
Indeed, we were not able to detect HBD2 in skin biopsies,
confirming the observations of Harder et al. (1997) that
HBD2 is expressed at very low levels in normal skin,
although HBD2 has been shown to be quite important for
protecting the epithelium against many different bacteria
(Chung and Dale, 2004). However, using confocal micro-
scopy and quantitative real-time PCR we have shown that
HBD3 in particular is expressed at low levels in normal skin
(Nomura et al., 2003), confirming the observation of
Sorensen et al. (2006), in which HBD3 was clearly detected
in normal skin by Western analysis. Although the constitutive
expression of HBD3 maintains an average of 1105 mRNA
copies per mg of skin, staining of the skin for HBD3 peptide
reveals that accumulation is not uniform. Therefore, HBD3
mRNA levels may be substantially higher than the average in
those cells of the skin samples, which express the peptide.
Although Sorensen et al. (2006) have shown that simple
wounding of the skin can stimulate HBD3 expression via
transactivation of the EGF receptor, this process requires 3–4
days to significantly elevate mRNA for HBD3. If the innate
immune response which contains S. aureus infections truly
required 3–4 days for induction (Sorensen et al., 2006),
S. aureus would be expected to cause far more morbidity and
mortality than it currently does, as a large percentage of
people are colonized with S. aureus (Fridkin et al., 2005).
Therefore, the hypothesis that there exists an innate mechan-
ism to sterilize small inoculae of bacteria into the epidermis is
reasonable.
Our investigation of the microbicidal mechanism of
keratinocytes suggested a model in which AMP stored in the
cells was mobilized onto the bacteria (Figure 6), which
occurred at the same time as internalization. Mobilization of
vesicles containing antimicrobial substances into phagosomes
containing microbes is a hallmark of bacterial killing by
professional phagocytes. Fusion of granules with phagosomes
in neutrophils allows application of antimicrobial substances
contained in them with minimal dilution, as compared with
extracellular secretion (Cauza et al., 2002). Binding and
internalization of S. aureus by keratinocytes associated with
fusion of vesicles containing defensins may account for the
requirement for contact between the bacteria and the cells, as
the same amount of defensin secreted into the medium was too
dilute to be effective. Indeed, S. aureus exposed to cell-free
medium harvested from keratinocyte cultures exposed to S.
aureus were unaffected by the conditioned medium. Therefore,
binding and internalization of S. aureus by the keratinocytes
may allow exposure to concentrated AMP, which could
enhance their antimicrobial efficacy.
In order to link our observations with isolated keratinocytes
to processes, which operate in human skin, we examined the
ability of keratinocytes in skin to bind, internalize, and
mobilize defensins onto bacteria. The punch skin biopsies
used created a surface containing cells, which were bisected by
the instrument. However, after 24 hours in culture, the dead
cells had been replaced by viable keratinocytes at the surface.
The surface keratinocytes were indeed able to bind and
internalize S. aureus, consistent with our observations in tissue
culture. In addition, AMPs were mobilized onto the bacteria.
However, although HBD1, HBD3, and LL37 were present in
most of the keratinocytes, only HBD3 was mobilized at
microbicidal levels onto S. aureus, which came into contact
with the cells. Therefore, it is likely that the antimicrobial
mechanism operative in cultured keratinocytes also works in
human skin. However, it was not possible to make a causal link
between accumulation of defensins on the bound S. aureus and
the microbicidal mechanism without conducting depletion
studies, to determine if inhibition of defensin activity resulted in
inhibition of bacterial killing.
Glaser et al. (2005) were able to demonstrate that
psoriasin was critical for preventing colonization of skin by
E. coli by antagonizing that peptide with antibodies, and
observing the effect on bacterial viability. We employed a
similar technique, depleting LL37, HBD1, HBD2, and HBD3
from keratinocyte cultures using specific antisera. This
revealed that killing could be substantially inhibited by
antagonizing HBD2 and HBD3, but not HBD1 or LL37. This
confirms that the rapid S. aureus killing mechanism of
cultured keratinocyte operates in a compartment accessible
to antibodies, and involves HBD2 and HBD3. In human skin
explants, bacteria which came into contact with the
keratinocytes accumulated approximately twice as much
HBD3 as those in contact with cultured keratinocytes.
However, during the 1 hour time frame of rapid killing,
LL37 was not deposited on the bacteria in significant amounts
by skin cells. Also, in contrast to cultured keratinocytes,
HBD2 was expressed by very few keratinocytes in the skin
explants, and S. aureus were not observed in contact with
those cells. This difference between AMP expression by
cultured keratinocytes in comparison with keratinocytes in
skin is likely due to differentiation of the cells in culture using
defined medium, which does not perfectly reflect the in vivo
situation in skin. However, as the contribution of HBD2 to
the killing mechanism in culture was considerably less than
that of HBD3, and the levels of HBD3 in the skin cells were
approximately twice that in cultured keratinocytes, the
increased HBD3 likely compensates for the lack of HBD2.
Therefore, we conclude that HBD3 is both necessary and
sufficient to account for the constitutive ability of human
keratinocytes to kill S. aureus within minutes of contact
with the cell surface. As we were unable to measure killing of
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S. aureus in contact with skin in situ, it is possible that other
host defense molecules play a role in early killing by
keratinocytes in skin, such as lysozyme or RNase 7 (Harder
and Schroder, 2002). However, the average level of HBD3
deposited on S. aureus by keratinocytes in skin suggests that
killing should be quite rapid even in the absence of other
mediators. It is important to note that not all of the bacteria in
contact with the skin were exposed to sufficient HBD3 to
suggest killing. Those bacteria at the lower end of the
exposure distribution might have had high levels of other host
defense molecules, which we have not examined in these
experiments. It is likely that complete sterilization of an
inoculation of S. aureus into the keratinocyte layers or
beyond would require multiple, complementary mechan-
isms, deposition of HBD3 being only one of them.
In summary, our data demonstrate that human keratino-
cytes possess a potent and previously unrecognized consti-
tutive mechanism to rapidly kill S. aureus, which come into
contact with them. The mechanism involves association of
the bacteria with the cell surface, followed by elaboration of
AMP onto the bacteria. The most important of the AMP for
killing of S. aureus by the cultured keratinocytes were HBD2
and HBD3, as evidenced by the ability of antibodies to these
two AMP to inhibit killing when added to the medium.
Examination of this process in samples of human skin
revealed that HBD3 mRNA and peptide was expressed in
healthy skin, and deposited on cell-associated S. aureus at
twice the level observed in cultured keratinocytes, whereas
HBD2 did not appear to participate in killing by keratinocytes
in skin. Despite operation of the killing mechanism at the cell
surface, the remains of the dead and dying bacteria are
rapidly internalized by the keratinocytes. This may serve to
limit inflammation by sequestering proinflammatory sub-
stances born by S. aureus. Therefore, keratinocytes contribute
to innate immune defense of the host by directly killing
bacteria utilizing HBD3, and sequestration of the products
via internalization.
MATERIALS AND METHODS
Reagents
LL37 was synthesized by the Molecular Resource Center at National
Jewish Medical and Research Center (NJMRC; Denver, CO) using
standard T-boc reagents, and purified to homogeneity via reversed
phase-HPLC. HBD1, HBD2, and HBD3 were the generous gifts of
Wuyuan Lu, University of Maryland. Human neutrophil peptide 1
was the gift of Jacek Lubkowski, National Cancer Institute. All
peptides were resuspended at 1 mg/ml, in 0.01% acetic acid,
aliquoted and stored at 801C until use. l-NAME, 40,6-diamidino-
2-phenylindole (DAPI), and o-phenylene diamine were obtained
from Sigma (St Louis, MO).
Skin biopsies
The skin of normal healthy donors, not taking systemic or topical
medications, was harvested following provision of informed consent
as per a protocol approved and monitored by the NJMRC
institutional review board, in accordance with the Declaration of
Helsinki Principles. Four 2 mm skin biopsies were collected from
each donor, and cultured overnight at 371C, 5% CO2 to allow for
involution of damaged cells at the cut edge of the tissue. The
biopsies were then exposed to S. aureus (Wood 46) labeled with
Texas Red for 5–60 minutes, after which they were rinsed three times
with KGM, and fixed with 4% paraformaldehyde.
Keratinocytes
Normal human neonatal keratinocytes were obtained from Cascade
Biologics (Portland, OR). The cells were cultured in EpiLife basal
medium supplemented with HKGS-V2 (Cascade Biologics). The
cells were frozen at passage two, and used for these studies at
passage three. The cells were cultured at 5 103 in coated (Coating
Matrix, Cascade Biologics) 24-well tissue culture plates. When the
cells reached 50% confluence, the medium was changed and CaCl2
was added to 1.3 mM in order to induce differentiation (Stanley and
Yuspa, 1983). The cells were then cultured an additional 5 days,
changing the medium every other day before use. The human
keratinocyte-like cell line HaCaT was obtained from American Type
Culture Collection (ATCC, Rockville, MD), and maintained in
DMEM containing 10% fetal bovine serum, L-glutamine, penicillin/
streptomycin, 1 minimal essential medium vitamin solution
(Gibco-Invitrogen, Carlsbad, CA), and non-essential amino acids
(Gibco-Invitrogen). Twenty-four hours before a killing assay, the
cells were seeded into 24-well plates at approximately 2 105 cells/
ml, and allowed to incubate overnight with antibiotic-free minimal
essential medium at 371C. At the time of the killing assays, the wells
contained 4–5 105 cells each.
Neutrophils
Human neutrophils were isolated from normal healthy individuals
according to a protocol reviewed and approved by the Institutional
Review Board (IRB) using a Percoll (Pharmacia, Piscataway, NJ)
density gradient (Sala et al., 1999). In brief, 4.4 ml of 3.8% (w/v)
sodium citrate (Fisher Scientific, Pittsburgh, PA) was added to 40 ml
of heparinized blood. The blood was then centrifuged at 400 g for
20 min. The plasma layer was then removed, 5 ml of 6% (w/v)
dextran (Pharmacia) was then added to the pelleted whole blood, the
total volume was brought up to 50 ml with saline and mixed gently.
The cell suspension was then left for 30 minutes at room temperature
to allow the red blood cells to settle. The upper white blood cell
layer was removed, centrifuged at 400 g for 10 minutes, the
supernatant discarded and the pellet resuspended in 2 ml of
autologous plasma. The cell suspension was then under-laid with a
42% (w/v) followed by a 51% (w/v) Percoll gradient and centrifuged
at 350 g for 10 minutes. The resulting neutrophil-rich layer was
carefully removed. Neutrophils were then resuspended in phos-
phate-buffered saline (PBS), centrifuged at 350 g for 10 minutes,
and the supernatant discarded. The resulting neutrophil pellet was
then resuspended in HBSS.
S. aureus
S. aureus ATCC strain numbers 29213 and 10832 (Wood 46) were
employed in our experiments. S. aureus was grown overnight in
tryptic soy broth at 371C with aeration. S. aureus was radioactively
labeled with 0.01 mCi 3H uracil (Amersham Pharmacia, Piscataway,
NJ). For each experiment, the bacterial cells were washed three
times by centrifugation, and resuspension in 1 PBS. Opsonization
of S. aureus was carried out at 371C with either antibody
opsonization at a 1:1,000 dilution with mouse Anti-Staph A
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(Research Diagnostics Inc., Flander, NJ) and/or serum opsonized
with 10% heat-inactivated human plasma obtained from healthy
donors. Bacterial concentration was determined by optical density
reading of the bacteria measured in a Beckman spectrophotometer.
Bactericidal assay
Twenty-four hours before the experiment, the cell culture medium
was replaced with antibiotic-free media containing all supplements
and 1.3 mM CaCl2. At the time of the experiment, fresh antibiotic-free
media with 1 106 bacteria/ml was inoculated into each well. Cells
were co-incubated with bacteria for 1 hour at 371C under 5% CO2,
rinsed three times with 1 PBS and the monolayers were detached
from the plates by adding 500 ml of trypsin/EDTA solution 1
(Cascade Biologics). Following detachment from the plate 500 ml of
trypsin neutralizing solution 1 (Cascade Biologics) was added. The
cells were lysed by resuspension in 500ml of sterile deionized water.
The cell lysates were quantified for total S. aureus by radioactive
decay of 3H measured by a Beckman scintillation counter, and
serially diluted 10- to 1,000-fold and plated onto tryptic soy agar
plates to quantify the viable, cell associated S. aureus upon
formation of colonies.
For studies examining inhibition of bactericidal activity by
keratinocytes, inhibitors such as l-NAME, colchicine, amiloride, or
antibodies to AMPs were added to the cell culture medium at various
concentrations 1 hour before addition of bacteria. The bacteria were
then added, incubated, and the percentage of viable bacteria
determined after 1 hour as above.
Internalization assay
The assays were performed as described above with the following
alterations: the bacteria were not labeled with 3H uracil. After the
1 hour incubation at 371C under 5% CO2, KGM supplemented with
100mg/ml gentamicin was added to each well and incubated for an
additional hour to kill any extracellular S. aureus. The cultures were
then rinsed three times, lysed, and bacteria plated to determine the
number of viable colonies as described above. The data represent
total viable bacteria, which survive gentamicin, implying that they
were protected within the cells.
Imaging
The Woods strain, ATCC 10832 was used for imaging, due to
markedly reduced nonspecific antibody binding (Gross et al., 1978).
The bacteria were surface labeled with 10mM Texas Red, succini-
midyl ester in PBS for 30 minutes at 371C, which results in a covalent
bond between bacterial surface macromolecules and the fluoro-
phore. The unbound label was then removed by centrifugation and
resuspension in 1 tryptic soy broth three times. The density of the
bacteria was then estimated by absorbance as above. Keratinocytes
were cultivated and differentiated as above in 24-well plates
containing 12 mm round no. 1 coverglasses (Fisher Scientific). The
fluorescently labeled bacteria were then added to the keratinocyte
cultures for intervals of 1 minute to 1 hour, after which the unbound
bacteria were removed by vigorous rinsing, and the cultures fixed
with 4% paraformaldehyde overnight at 41C.
For staining with antibodies to AMPs, samples were permeabi-
lized and blocked with PBS containing 3% BSA, 5% human serum,
and 0.1% Tween 20 (staining buffer). Polyclonal rabbit anti-HBD1 at
10 mg/ml (Alpha Diagnostics, San Antonio, TX, 1:100), polyclonal
rabbit anti-HBD2 at 2.5 mg/ml (Alpha Diagnostics, 1:250), poly-
clonal rabbit anti-HBD3 at 10mg/ml HBD3 (Orbigen, San Diego,
CA, 1:100), and polyclonal rabbit anti-LL37 at 10 mg/ml (HyCult
Biotechnology, 1:100), or preimmune serum were diluted as noted
into staining buffer, and incubated with the samples overnight at
41C. After washing to remove unbound antibody, the samples were
developed with polyclonal goat anti-rabbit antibody conjugated to
FITC. The samples were then counterstained with wheat germ
agglutinin-Cy-5 (Molecular Probes, Eugene, OR) and DAPI. After
staining, the coverslips were mounted on glass slides with the
attached cells toward the slide using 3% o-phenylene diamine in
90% glycerol, 1 PBS as an antifade and mounting medium. The
samples were then imaged using a digital imaging workstation (Zeiss
Axiovert 200 M microscope; Carl Zeiss Microimaging Inc., Thom-
wood, NY) controlled by Slidebook software (Intelligent Imaging
Innovations, Denver, CO). A series of images in the z axis was
collected at intervals of 0.2 mm, until the feature of interest was
completely captured. Images were deblurred using nearest neighbors
deconvolution (Kisich et al., 2002).
Quantitation of mRNA levels in normal skin
Total RNA was isolated from normal skin explants by chloroform:-
phenol extraction and isopropanol precipitation according to
manufacturer’s guidelines (Sigma Chemical Co., St Louis, MO).
RNeasy Mini Kits (Qiagen, Valencia, CA) were used according to the
manufacturer’s protocol to isolate RNA from cell cultures and to
further purify RNA from skin explants. One microgram of RNA was
reverse transcribed in a 20 ml reaction containing Random Primers
(Invitrogen, Carlsbad, CA), RNase Inhibitor (Invitrogen), and Super-
script III enzyme (Invitrogen). Real-time PCR was performed and
analyzed by the dual-labeled fluorigenic probe method using an ABI
Prism 7000 sequence detector (Applied Biosystems, Foster City, CA).
Primers and probes for human GAPDH were purchased from
Applied Biosystems. HBD3 primer and probes were prepared as
described previously (Nomura et al., 2003). The TaqMan probes
were purchased from Applied Biosystems and were 50 labeled with
6-carboxyfluorescein (FAM) and 30-labeled with 6-carboxy-tetra-
methylrhodamine (TAMRA). Amplification reactions were performed
in MicroAmp optical tubes (Applied Biosystems) in a 25 ml volume
containing 2 TaqMan Master Mix (Applied Biosystems), 900 nM
forward primer, 900 nM reverse primer, 200 nM probe, and the
template RNA. Thermal cycling conditions were 501C for 2 minutes,
951C for 10 minutes for one cycle. Subsequently, 40 cycles of
amplification were performed at 941C for 15 seconds and 601C for
1 minute. Standard curves were generated from GAPDH and HBD3
mRNA synthesized via in vitro transcription, according to the
manufacturer’s instructions (T7 megascript, Ambion, Austin, TX).
Quantitation of AMP exposure in cultured keratinocytes
Intensity values of at least 50 bacteria per concentration were used to
construct standard intensity versus exposure curves for LL37, HBD1,
HBD2, and HBD3. The intensity values after subtraction of the
average background of samples exposed to control antibody were fit
to lines using regression analysis. The line was considered a valid
representation of the data if a correlation coefficient (R2) of 0.95 or
greater was reported. Keratinocyte samples stained and imaged in
the same experiment as the standard samples were imaged using
identical image capture settings as the standards. At least 20 bacteria
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in each of triplicate wells were imaged for each AMP stain, each
bacterium’s intensity was interpolated to equivalent in vitro AMP
exposure via the respective line equations. Equivalent exposure
values were then compared with samples stained with the
appropriate control antibody via t-test.
Quantitation of AMP exposure in human skin was analyzed using
similar techniques as above, with the exception that four biopsies
were examined from each of four individuals. Serial sections from
each biopsy were stained and imaged until at least 10 bacteria in
contact with the keratinocyte layers were observed for each biopsy,
for a total of 40 bacteria per AMP stain per individual. Intensities of
each bacterium were interpolated to equivalent AMP exposure via
the standard curves, and the values were compared to bacteria in
serial sections stained with control antibody. Average equivalent in
vitro exposure values for each stain were compared with control
antibody via t-test, and a Po0.05 was considered significant.
Statistical analyses
S. aureus killing assays were analyzed by comparing the means of
total versus viable bacteria from triplicate samples receiving different
treatments using t-test. A Po0.05 was considered significant. Each
comparison was performed three times.
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